User profiles for Qaid Ahmed Shagera
 | Qaid Ahmed ShageraNuclear Medicine Resident, HUB, Hôpital d'Erasme Verified email at hubruxelles.be Cited by 145 |
68Ga-PSMA PET/CT for response assessment and outcome prediction in metastatic prostate cancer patients treated with taxane-based chemotherapy
QA Shagera, C Artigas, I Karfis, G Critchi… - Journal of Nuclear …, 2022 - Soc Nuclear Med
We aimed to evaluate the role of PET targeting the prostate-specific membrane antigen (PSMA)
for response assessment in metastatic prostate cancer (PCa) patients treated with taxane…
for response assessment in metastatic prostate cancer (PCa) patients treated with taxane…
[HTML][HTML] Peering through the PSMA PET Lens: The Role of the European Association of Urology Biochemical Recurrence Risk Groups after Radical Prostatectomy
…, A Baudewyns, HA Bourgeno, QA Shagera… - Cancers, 2023 - mdpi.com
Simple Summary After radical prostatectomy (RP), about a third of patients present with BCR.
The European Association of Urology (EAU) biochemical recurrence (BCR) risk grouping …
The European Association of Urology (EAU) biochemical recurrence (BCR) risk grouping …
Prognostic value of metabolic tumour volume on baseline 18F-FDG PET/CT in addition to NCCN-IPI in patients with diffuse large B-cell lymphoma: further stratification …
Purpose The purpose of this study was to determine the prognostic value of metabolic
volumetric parameters as a quantitative index on pre-treatment 18 F-FDG PET/CT in addition to …
volumetric parameters as a quantitative index on pre-treatment 18 F-FDG PET/CT in addition to …
Multicenter external validation of a nomogram for predicting positive prostate-specific membrane antigen/positron emission tomography scan in patients with prostate …
…, C Artigas, J Leite, P Corona, QA Shagera… - European Urology …, 2023 - Elsevier
Background A nomogram has recently been developed to predict 68 Ga-labeled prostate-specific
membrane antigen (PSMA)-11 positron emission tomography (PET)/computed …
membrane antigen (PSMA)-11 positron emission tomography (PET)/computed …
[HTML][HTML] Oligometastatic Disease Detection with 68Ga-PSMA-11 PET/CT in Hormone-Sensitive Prostate Cancer Patients (HSPC) with Biochemical Recurrence after …
Simple Summary The early treatment of oligometastatic disease (OMD) is a promising
therapeutic option for prostate cancer as it has the potential of delaying androgen-deprivation …
therapeutic option for prostate cancer as it has the potential of delaying androgen-deprivation …
[HTML][HTML] Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin's Lymphoma
The aim of the study was to assess the predictive value of interim FDG-PET/CT (iPET) in
patients with Hodgkin’s lymphoma (HL) treated with Adriamycin, bleomycin, vinblastine and …
patients with Hodgkin’s lymphoma (HL) treated with Adriamycin, bleomycin, vinblastine and …
Basal and acetazolamide brain perfusion SPECT in internal carotid artery stenosis
Internal carotid artery (ICA) stenosis including Moyamoya disease needs revascularization
when hemodynamic insufficiency is validated. Vascular reserve impairment was the key to …
when hemodynamic insufficiency is validated. Vascular reserve impairment was the key to …
PSMA PET/CT for Response Assessment and Overall Survival Prediction in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Androgen …
QA Shagera, I Karfis, P Kristanto… - Journal of Nuclear …, 2023 - Soc Nuclear Med
We aimed to evaluate the role of prostate-specific membrane antigen (PSMA) PET/CT for
response assessment and outcome prediction in patients with metastatic castration-resistant …
response assessment and outcome prediction in patients with metastatic castration-resistant …
[HTML][HTML] The Diagnostic and Predictive Value of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Laryngeal Squamous Cell …
Simple Summary This retrospective study compares the diagnostic efficacy of 18 F-fluorodeoxyglucose
positron emission tomography/computed tomography ( 18 F-FDG PET/CT) in …
positron emission tomography/computed tomography ( 18 F-FDG PET/CT) in …
Tumor Volume on PSMA PET as a Prognostic Biomarker in Prostate Cancer Patients Treated with Cabazitaxel
QA Shagera, I Karfis, S Sideris, T Guiot… - Clinical nuclear …, 2022 - journals.lww.com
Purpose The aim of this study was to evaluate the prognostic value of 68 Ga-labeled
prostate-specific membrane antigen (PSMA) PET/CT in metastatic castration-resistant prostate …
prostate-specific membrane antigen (PSMA) PET/CT in metastatic castration-resistant prostate …